Stifel Resumes Mirum Pharmaceuticals (MIRM) at Buy, PT $89, 'stands out in what remains a discerning biotech tape'

Go back to Stifel Resumes Mirum Pharmaceuticals (MIRM) at Buy, PT $89, 'stands out in what remains a discerning biotech tape'
(NASDAQ: MIRM) Delayed: 100.64 +1.87 (1.89%)
Previous Close $98.77    52 Week High
Open $98.03    52 Week Low
Day High $101.31    P/E N/A 
Day Low $96.73    EPS
Volume 503,793